Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 16934439)

1.

Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use.

MacAdam H, Zaoutis TE, Gasink LB, Bilker WB, Lautenbach E.

Int J Antimicrob Agents. 2006 Oct;28(4):325-32. Epub 2006 Aug 24. Review.

PMID:
16934439
2.

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO.

Clin Infect Dis. 2001 Oct 15;33(8):1288-94. Epub 2001 Sep 14.

3.

Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.

Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E.

Clin Infect Dis. 2005 May 1;40(9):1317-24. Epub 2005 Mar 30.

4.

Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance.

Serefhanoglu K, Turan H, Timurkaynak FE, Arslan H.

Braz J Infect Dis. 2009 Dec;13(6):403-7.

5.

Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Park SY, Kang CI, Joo EJ, Ha YE, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.

Microb Drug Resist. 2012 Oct;18(5):518-24. doi: 10.1089/mdr.2012.0067. Epub 2012 Jun 28.

PMID:
22742454
6.
7.

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO.

Clin Infect Dis. 2001 Apr 15;32(8):1162-71. Epub 2001 Mar 26.

8.

Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.

Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E.

Pediatrics. 2005 Apr;115(4):942-9.

PMID:
15805368
10.

Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.

Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.

J Antimicrob Chemother. 2007 Sep;60(3):629-37. Epub 2007 Jun 27.

11.

Risk Factors for Ciprofloxacin Resistance in Bloodstream Infections Due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.

Kang CI, Kim SH, Kim DM, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW.

Microb Drug Resist. 2004 Spring;10(1):71-6.

PMID:
15140397
12.

[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].

de Cueto M, Hernández JR, López-Cerero L, Morillo C, Pascual A.

Enferm Infecc Microbiol Clin. 2006 Dec;24(10):613-6. Spanish.

PMID:
17194386
13.
15.

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection.

Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E.

Arch Intern Med. 2005 Jun 27;165(12):1375-80.

PMID:
15983286
16.

Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.

Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A; Norwegian ESBL Study Group.

J Clin Microbiol. 2007 Jan;45(1):199-205. Epub 2006 Nov 1.

17.

Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon.

Kanafani ZA, Mehio-Sibai A, Araj GF, Kanaan M, Kanj SS.

Am J Infect Control. 2005 Aug;33(6):326-32.

PMID:
16061138
18.

Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.

Martínez JA, Aguilar J, Almela M, Marco F, Soriano A, López F, Balasso V, Pozo L, Mensa J.

J Antimicrob Chemother. 2006 Nov;58(5):1082-5. Epub 2006 Sep 1.

19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk